Serum prostate-specific antigen (PSA), a serine protease that is produced by normal and malignant epithelial cells in the prostate, is not only a marker used for prostate cancer screening, but also, it identifies men of various prostatic conditions such a benign prostatic hyperplasia (BPH). Here, KLK3 is linked to prostate carcinoma.